News

Net Loss of ANG Lifesciences India reported to Rs 1.38 crore in the quarter ended March 2026 as against net loss of Rs 2.06 crore during the previous quarter ended March 2025. Sales rose 39.71% to Rs 23.50 crore in the quarter ended March 2026 as against Rs 16.82 crore during the previous quarter ended March 2025.For the full year,net loss reported to Rs 11.08 crore in the year ended March 2026 as against net loss of Rs 12.41 crore during the previous year ended March 2025. Sales rose 0.04% to Rs 92.89 crore in the year ended March 2026 as against Rs 92.85 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales23.5016.82 40 92.8992.85 0 OPM %11.36-4.16 -0.76-2.44 - PBDT0.67-2.47 LP -6.68-8.94 25 PBT-1.10-3.89 72 -13.01-15.70 17 NP-1.38-2.06 33 -11.08-12.41 11 Powered by Capital Market - Live News

ANG Lifesciences India will hold a meeting of the Board of Directors of the Company on 30 May 2026.

ANG Lifesciences India will hold a meeting of the Board of Directors of the Company on 14 February 2026.Powered by Capital Market - Live News

Net Loss of ANG Lifesciences India reported to Rs 2.95 crore in the quarter ended September 2025 as against net loss of Rs 2.09 crore during the previous quarter ended September 2024. Sales declined 20.77% to Rs 26.05 crore in the quarter ended September 2025 as against Rs 32.88 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales26.0532.88 -21 OPM %0.316.96 - PBDT-1.690.45 PL PBT-3.21-1.29 -149 NP-2.95-2.09 -41 Powered by Capital Market - Live News

ANG Lifesciences India will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live News